Skip to main content

Evaluation of Acute Rejection Rates in de novo Renal Transplant Recipients Following Thymoglobulin Induction, CNI-free, Nulojix (belatacept) -based Immunosuppression

Clinical Trial Grant
Duke Scholars

Administered By

Surgery, Abdominal Transplant Surgery

Awarded By

Bristol-Myers Squibb Company

Start Date

October 1, 2014

End Date

September 30, 2017
 

Administered By

Surgery, Abdominal Transplant Surgery

Awarded By

Bristol-Myers Squibb Company

Start Date

October 1, 2014

End Date

September 30, 2017